Themis Medicare Limited has informed the Exchange about press release dated 21-Mar-2022 titled Indian regulator approves VIRALEX for the treatment of mild to moderate COVID-19 in India
Themis Medicare Limited has informed the Exchange about press release dated 21-Mar-2022 titled Indian regulator approves VIRALEX for the treatment of mild to moderate COVID-19 in India